Using quantitative proteomics of patient fibroblasts and a CRISPR-Cas9 mediated TIMM50 HEK293 cell model of disease, we have established the first proteomic map of mitochondrial disease associated with TIMM50 pathogenic variants. This evidence concerns the gene TIMM50 and mitochondrial disease.